Can vitamin D deficiency affect the development of cancer? - review of the literature
DOI:
https://doi.org/10.12775/JEHS.2024.56.012Keywords
vitamin D, vitamin D deficiency, cancerAbstract
Introduction and purpose:
Over recent years, there has been a noticeable increase in cases of cancer around the world. At the same time, there is the problem of vitamin D deficiency, which may affect up to one-quarter of the population. The aim of this article is to link these two epidemics and organize knowledge about vitamin D and its multidirectional effects related to many diseases, especially cancer.
State of knowledge:
Many scientific works have proven that vitamin D has a beneficial effect not only on the known calcium-phosphate metabolism. Researchers emphasize its pleiotropic effect on many organs and systems in the human body, and thus on many diseases, including cancer. Studies show that vitamin D modulates the expression of many different miRNAs specific to various types of cancer. The results of in vitro and in vivo studies showed the effect of calcitriol on cell growth and development. It influences processes such as differentiation, proliferation, apoptosis, strengthens the immune system, and reduces oxidative stress.
Summary:
Based on accumulated research, we can conclude that vitamin D presumably regulates the entire process of tumorigenesis, from initiation to metastasis and cell-microenvironment interactions. However, some studies do not confirm these data or provide contradictory results. For this reason, it is necessary to deepen research on this topic in order to establish specific recommendations, therapeutic and preventive plans. However, vitamin D and its role in the pathogenesis of many diseases should not be underestimated. In cases of low vitamin D concentration in the body, its supplementation will be reasonable, considering the functional identity of this source compared to sun exposure or diet.
References
Mędrek M. Research on the effectiveness of cancer screening programs based on the medical documentation of the Amethyst Radiation Therapy Center in Krakow. Master’s thesis. RUJ; 2020
Jones G. The discovery and synthesis of the nutritional factor vitamin D. Int J Paleopathol. 2018 Dec;23:96-99. doi: 10.1016/j.ijpp.2018.01.002. Epub 2018 Jan 17. PMID: 30573171.
Giustina A, Adler RA, Binkley N, Bollerslev J, Bouillon R, Dawson-Hughes B, Ebeling PR, Feldman D, Formenti AM, Lazaretti-Castro M, Marcocci C, Rizzoli R, Sempos CT, Bilezikian JP. Consensus statement from 2nd International Conference on Controversies in Vitamin D. Rev Endocr Metab Disord. 2020 Mar;21(1):89-116. doi: 10.1007/s11154-019-09532-w. PMID: 32180081; PMCID: PMC7113202.
Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc. 2010 Aug;85(8):752-7; quiz 757-8. doi: 10.4065/mcp.2010.0138. PMID: 20675513; PMCID: PMC2912737.
Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001 Aug;22(4):477-501. doi: 10.1210/edrv.22.4.0437. PMID: 11493580.
Marcinkowska M, Mickiewicz A, Fijałkowski, M. Plejotropowe działanie witaminy D. Choroby Serca i Naczyń. 2019;16(1):45-52. DOI: 10.5603/ChSiN.2019.0007
Aydın CG, Dinçel YM, Arıkan Y, Taş SK, Deniz S. The effects of indoor and outdoor sports participation and seasonal changes on vitamin D levels in athletes. SAGE Open Med. 2019 Mar 12;7:2050312119837480. doi: 10.1177/2050312119837480. PMID: 30886717; PMCID: PMC6415475.
Spiro A, Buttriss JL. Vitamin D: An overview of vitamin D status and intake in Europe. Nutr Bull. 2014 Dec;39(4):322-350. doi: 10.1111/nbu.12108. PMID: 25635171; PMCID: PMC4288313.
Płudowski P, Karczmarewicz E, Bayer M, Carter G, Chlebna-Sokół D, Czech-Kowalska J, Dębski R, Decsi T, Dobrzańska A, Franek E, Głuszko P, Grant WB, Holick MF, Yankovskaya L, Konstantynowicz J, Książyk JB, Księżopolska-Orłowska K, Lewiński A, Litwin M, Lohner S, Lorenc RS, Lukaszkiewicz J, Marcinowska-Suchowierska E, Milewicz A, Misiorowski W, Nowicki M, Povoroznyuk V, Rozentryt P, Rudenka E, Shoenfeld Y, Socha P, Solnica B, Szalecki M, Tałałaj M, Varbiro S, Żmijewski MA. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013;64(4):319-27. doi: 10.5603/ep.2013.0012. PMID: 24002961.
Pludowski P, Holick MF, Grant WB, et al. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol. 2018; 175: 125–135, doi: 10.1016/j.jsbmb.2017.01.021, indexed in Pubmed: 28216084.
Piotrowska A, Wierzbicka J, Żmijewski MA. Vitamin D in the skin physiology and pathology. Acta Biochim Pol. 2016; 63(1): 17–29, doi: 10.18388/abp.2015_1104, indexed in Pubmed: 26824295.
Haussler MR, Jurutka PW, Mizwicki M, et al. Vitamin D receptor (VDR)-mediated actions of 1 a, 25(OH)2 vitamin D 3: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab. 2011; 25(4): 543–559, doi: 10.1016/j.beem.2011.05.010, indexed in Pubmed: 21872797.
Simpson RU, Thomas GA, Arnold AJ. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem. 1985 Jul 25;260(15):8882-91. PMID: 2991224.
Bivona G, Agnello L, Bellia C, Iacolino G, Scazzone C, Lo Sasso B, Ciaccio M. Non-Skeletal Activities of Vitamin D: From Physiology to Brain Pathology. Medicina (Kaunas). 2019 Jul 5;55(7):341. doi: 10.3390/medicina55070341. PMID: 31284484; PMCID: PMC6680897.
Kalueff AV, Lou YR, Laaksi I, Tuohimaa P. Impaired motor performance in mice lacking neurosteroid vitamin D receptors. Brain Res Bull. 2004 Jul 30;64(1):25-9. doi: 10.1016/j.brainresbull.2004.04.015. PMID: 15275953.
Gil Á, Plaza-Diaz J, Mesa MD. Vitamin D: Classic and Novel Actions. Ann Nutr Metab. 2018;72(2):87-95. doi: 10.1159/000486536. Epub 2018 Jan 18. PMID: 29346788.
Lin AM, Chen KB, Chao PL. Antioxidative effect of vitamin D3 on zinc-induced oxidative stress in CNS. Ann N Y Acad Sci. 2005 Aug;1053:319-29. doi: 10.1196/annals.1344.028. PMID: 16179538.
Krasowska K, Skrobot W, Liedtke E, Sawicki P, Flis DJ, Dzik KP, Libionka W, Kloc W, Kaczor JJ. The Preoperative Supplementation With Vitamin D Attenuated Pain Intensity and Reduced the Level of Pro-inflammatory Markers in Patients After Posterior Lumbar Interbody Fusion. Front Pharmacol. 2019 May 22;10:527. doi: 10.3389/fphar.2019.00527. PMID: 31191300; PMCID: PMC6539202.
Skrobot W, Liedtke E, Krasowska K, Dzik KP, Flis DJ, Samoraj-Dereszkiewicz A, Libionka W, Kortas J, Kloc W, Antosiewicz J, Kaczor JJ. Early Rehabilitation Program and Vitamin D Supplementation Improves Sensitivity of Balance and the Postural Control in Patients after Posterior Lumbar Interbody Fusion: A Randomized Trial. Nutrients. 2019 Sep 12;11(9):2202. doi: 10.3390/nu11092202. PMID: 31547377; PMCID: PMC6769962.
Skrobot W, Perzanowska E, Krasowska K, Flis DJ, Dzik KP, Kloc W, Kaczor JJ, Antosiewicz J. Vitamin D Supplementation Improves the Effects of the Rehabilitation Program on Balance and Pressure Distribution in Patients after Anterior Cervical Interbody Fusion-Randomized Control Trial. Nutrients. 2020 Dec 18;12(12):3874. doi: 10.3390/nu12123874. PMID: 33352920; PMCID: PMC7766157.
Garland CF, Kim JJ, Mohr SB, Gorham ED, Grant WB, Giovannucci EL, Baggerly L, Hofflich H, Ramsdell JW, Zeng K, Heaney RP. Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am J Public Health. 2014 Aug;104(8):e43-50. doi: 10.2105/AJPH.2014.302034. Epub 2014 Jun 12. PMID: 24922127; PMCID: PMC4103214.
Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, Shoenfeld Y, Lerchbaum E, Llewellyn DJ, Kienreich K, Soni M. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev. 2013 Aug;12(10):976-89. doi: 10.1016/j.autrev.2013.02.004. Epub 2013 Mar 28. PMID: 23542507.
Okuno H, Kishimoto KN, Hatori M, Itoi E. 1α,25-dihydroxyvitamin D₃ enhances fast-myosin heavy chain expression in differentiated C2C12 myoblasts. Cell Biol Int. 2012 May 1;36(5):441-7. doi: 10.1042/CBI20100782. PMID: 22276695.
Peterson AL, Murchison C, Zabetian C, Leverenz JB, Watson GS, Montine T, Carney N, Bowman GL, Edwards K, Quinn JF. Memory, mood, and vitamin D in persons with Parkinson's disease. J Parkinsons Dis. 2013;3(4):547-55. doi: 10.3233/JPD-130206. PMID: 24081441; PMCID: PMC3966187.
Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, Bischoff-Ferrari HA, Cavalier E, Ebeling PR, Fardellone P, Gandini S, Gruson D, Guérin AP, Heickendorff L, Hollis BW, Ish-Shalom S, Jean G, von Landenberg P, Largura A, Olsson T, Pierrot-Deseilligny C, Pilz S, Tincani A, Valcour A, Zittermann A. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev. 2010 Sep;9(11):709-15. doi: 10.1016/j.autrev.2010.06.009. Epub 2010 Jul 1. PMID: 20601202.
Zeljic K, Supic G, Magic Z. New insights into vitamin D anticancer properties: focus on miRNA modulation. Mol Genet Genomics. 2017; 292(3): 511–524. doi: 10.1007/s00438-017-1301-9
Chang S, Gao L, Yang Y, Tong D, Guo B, Liu L, Li Z, Song T, Huang C. miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells. Oncotarget. 2015 Apr 10;6(10):7675-85. doi: 10.18632/oncotarget.3048. PMID: 25762621; PMCID: PMC4480708.
Kuryłowicz A, Bednarczuk T, Nauman J. Wpływ niedoboru witaminy D na rozwój nowotworów i chorób autoimmunologicznych [The influence of vitamin D deficiency on cancers and autoimmune diseases development]. Endokrynol Pol. 2007 Mar-Apr;58(2):140-52. Polish. PMID: 17578830.
Bouillon R, Eelen G, Verlinden L, Mathieu C, Carmeliet G, Verstuyf A. Vitamin D and cancer. J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):156-62. doi: 10.1016/j.jsbmb.2006.09.014. PMID: 17113979.
Desprez PY, Poujol D, Falette N, Lefebvre MF, Saez S. 1,25-Dihydroxyvitamin D3 increases epidermal growth factor receptor gene expression in BT-20 breast carcinoma cells. Biochem Biophys Res Commun. 1991 Apr 15;176(1):1-6. doi: 10.1016/0006-291x(91)90880-g. PMID: 1673338.
Beer TM, Myrthue A. Calcitriol in cancer treatment: from the lab to the clinic. Mol Cancer Ther. 2004 Mar;3(3):373-81. PMID: 15026558.
Elstner E, Linker-Israeli M, Said J, Umiel T, de Vos S, Shintaku IP, Heber D, Binderup L, Uskokovic M, Koeffler HP. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res. 1995 Jul 1;55(13):2822-30. PMID: 7796409.
Xu HM, Tepper CG, Jones JB, Fernandez CE, Studzinski GP. 1,25-Dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Exp Cell Res. 1993 Dec;209(2):367-74. doi: 10.1006/excr.1993.1322. PMID: 8262155.
Flanagan L, Packman K, Juba B, O'Neill S, Tenniswood M, Welsh J. Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion. J Steroid Biochem Mol Biol. 2003 Feb;84(2-3):181-92. doi: 10.1016/s0960-0760(03)00028-1. PMID: 12711002.
Hansen CM, Frandsen TL, Brünner N, Binderup L. 1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro. Clin Exp Metastasis. 1994 May;12(3):195-202. doi: 10.1007/BF01753887. PMID: 8194194.
Konety BR, Lavelle JP, Pirtskalaishvili G, Dhir R, Meyers SA, Nguyen TS, Hershberger P, Shurin MR, Johnson CS, Trump DL, Zeidel ML, Getzenberg RH. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. J Urol. 2001 Jan;165(1):253-8. doi: 10.1097/00005392-200101000-00074. PMID: 11125420.
Young MR, Ihm J, Lozano Y, Wright MA, Prechel MM. Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence. Cancer Immunol Immunother. 1995 Jul;41(1):37-45. doi: 10.1007/BF01788958. PMID: 7641218.
Bao BY, Yao J, Lee YF. 1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis. 2006 Sep;27(9):1883-93. doi: 10.1093/carcin/bgl041. Epub 2006 Apr 19. PMID: 16624828.
Reichrath J, Kamradt J, Zhu XH, Kong XF, Tilgen W, Holick MF. Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas. Am J Pathol. 1999 Aug;155(2):583-9. doi: 10.1016/s0002-9440(10)65153-x. PMID: 10433950; PMCID: PMC1866876.
Reichrath J, Rafi L, Müller SM, Mink D, Reitnauer K, Tilgen W, Schmidt W, Friedrich M. Immunohistochemical analysis of 1,25-dihydroxyvitamin D3 receptor in cervical carcinoma. Histochem J. 1998 Aug;30(8):561-7. doi: 10.1023/a:1003283117492. PMID: 9792274.
Nejentsev S, Godfrey L, Snook H, Rance H, Nutland S, Walker NM, Lam AC, Guja C, Ionescu-Tirgoviste C, Undlien DE, Rønningen KS, Tuomilehto-Wolf E, Tuomilehto J, Newport MJ, Clayton DG, Todd JA. Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. Hum Mol Genet. 2004 Aug 1;13(15):1633-9. doi: 10.1093/hmg/ddh169. Epub 2004 Jun 2. PMID: 15175274.
Chen WY, Bertone-Johnson ER, Hunter DJ, Willett WC, Hankinson SE. Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2335-9. doi: 10.1158/1055-9965.EPI-05-0283. PMID: 16214913.
John EM, Schwartz GG, Koo J, Van Den Berg D, Ingles SA. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res. 2005 Jun 15;65(12):5470-9. doi: 10.1158/0008-5472.CAN-04-3134. PMID: 15958597.
Carling T, Rastad J, Akerström G, Westin G. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab. 1998 Jul;83(7):2255-9. doi: 10.1210/jcem.83.7.4862. PMID: 9661591.
Graafmans WC, Lips P, Ooms ME, van Leeuwen JP, Pols HA, Uitterlinden AG. The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype. J Bone Miner Res. 1997 Aug;12(8):1241-5. doi: 10.1359/jbmr.1997.12.8.1241. PMID: 9258754.
Marc J, Prezelj J, Komel R, Kocijancic A. VDR genotype and response to etidronate therapy in late postmenopausal women. Osteoporos Int. 1999;10(4):303-6. doi: 10.1007/s001980050231. PMID: 10692979.
Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA. Prediction of bone density from vitamin D receptor alleles. Nature. 1994 Jan 20;367(6460):284-7. doi: 10.1038/367284a0. Erratum in: Nature 1997 May 1;387(6628):106. PMID: 8161378.
Giammanco M, Di Majo D, La Guardia M, Aiello S, Crescimannno M, Flandina C, Tumminello FM, Leto G. Vitamin D in cancer chemoprevention. Pharm Biol. 2015;53(10):1399-434. doi: 10.3109/13880209.2014.988274. Epub 2015 Apr 9. PMID: 25856702.
Jeon SM, Shin EA. Exploring vitamin D metabolism and function in cancer. Exp Mol Med. 2018 Apr 16;50(4):1-14. doi: 10.1038/s12276-018-0038-9. PMID: 29657326; PMCID: PMC5938036.
Gilaberte Y, Aguilera J, Carrascosa JM, Figueroa FL, Romaní de Gabriel J, Nagore E. La vitamina D: evidencias y controversias [Vitamin D: evidence and controversies]. Actas Dermosifiliogr. 2011 Oct;102(8):572-88. Spanish. doi: 10.1016/j.ad.2011.03.015. Epub 2011 May 26. PMID: 21620350.
J. Narbutt, P.A. Philipsen, A. Lesiak, T. Sandberg Liljendahl, D. Segerbäck, J. Heydenreich, D. Chlebna‐Sokol, P. Olsen, G.I. Harrison, A. Pearson, K. Baczynska, M. Rogowski‐Tylman, H.C. Wulf, A.R. Young, Children sustain high levels of skin DNA photodamage, with a modest increase of serum 25‐hydroxyvitamin D3, after a summer holiday in Northern Europe, British Journal of Dermatology, Volume 179, Issue 4, 1 October 2018, Pages 940–950, https://doi.org/10.1111/bjd.16668
Reddy KK, Gilchrest BA. Iatrogenic effects of photoprotection recommendations on skin cancer development, vitamin D levels, and general health. Clin Dermatol. 2011 Nov-Dec;29(6):644-51. doi: 10.1016/j.clindermatol.2011.08.027. PMID: 22014986.
Martin-Gorgojo A, Gilaberte Y, Nagore E. Vitamin D and Skin Cancer: An Epidemiological, Patient-Centered Update and Review. Nutrients. 2021 Nov 28;13(12):4292. doi: 10.3390/nu13124292. PMID: 34959844; PMCID: PMC8709188.
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588. Epub ahead of print. PMID: 33818764.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
Saginala K, Barsouk A, Aluru JS, Rawla P, Barsouk A. Epidemiology of Melanoma. Med Sci (Basel). 2021 Oct 20;9(4):63. doi: 10.3390/medsci9040063. PMID: 34698235; PMCID: PMC8544364.
Tang JY, Fu T, Lau C, Oh DH, Bikle DD, Asgari MM. Vitamin D in cutaneous carcinogenesis: part II. J Am Acad Dermatol. 2012 Nov;67(5):817.e1-11; quiz 827-8. doi: 10.1016/j.jaad.2012.07.022. PMID: 23062904; PMCID: PMC3706259.
Espié M, Wassermann J, de Kermadec E, Lalloum M, Coussy F. Vitamine D et cancers [Vitamin D and cancers]. Presse Med. 2013 Oct;42(10):1405-11. French. doi: 10.1016/j.lpm.2013.07.013. Epub 2013 Sep 17. PMID: 24051164.
Mahamat-Saleh Y, Aune D, Schlesinger S. 25-Hydroxyvitamin D status, vitamin D intake, and skin cancer risk: a systematic review and dose-response meta-analysis of prospective studies. Sci Rep. 2020 Aug 4;10(1):13151. doi: 10.1038/s41598-020-70078-y. PMID: 32753685; PMCID: PMC7403339.
Fang S, Sui D, Wang Y, Liu H, Chiang YJ, Ross MI, Gershenwald JE, Cormier JN, Royal RE, Lucci A, Wargo J, Hu MI, Gardner JM, Reveille JD, Bassett RL, Wei Q, Amos CI, Lee JE. Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein. J Clin Oncol. 2016 May 20;34(15):1741-7. doi: 10.1200/JCO.2015.64.1357. Epub 2016 Mar 21. PMID: 27001565; PMCID: PMC4966337.
Moreno-Arrones OM, Zegeer J, Gerbo M, Manrique-Silva E, Requena C, Traves V, Nagore E. Decreased vitamin D serum levels at melanoma diagnosis are associated with tumor ulceration and high tumor mitotic rate. Melanoma Res. 2019 Dec;29(6):664-667. doi: 10.1097/CMR.0000000000000638. PMID: 31469708.
Davies JR, Field S, Randerson-Moor J, Harland M, Kumar R, Anic GM, Nagore E, Hansson J, Höiom V, Jönsson G, Gruis NA, Park JY, Guan J, Sivaramakrishna Rachakonda P, Wendt J, Pjanova D, Puig S, Schadendorf D, Okamoto I, Olsson H, Affleck P, García-Casado Z, Puig-Butille JA, Stratigos AJ, Kodela E, Donina S, Sucker A, Hosen I, Egan KM, Barrett JH, van Doorn R, Bishop DT, Newton-Bishop J. An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study. Pigment Cell Melanoma Res. 2014 Mar;27(2):234-43. doi: 10.1111/pcmr.12193. Epub 2013 Dec 11. PMID: 24219834; PMCID: PMC4065372.
De Giorgi V, Gori A, Grazzini M, Rossari S, Oranges T, Longo AS, Lotti T, Gandini S. Epidemiology of melanoma: is it still epidemic? What is the role of the sun, sunbeds, Vit D, betablocks, and others? Dermatol Ther. 2012 Sep-Oct;25(5):392-6. doi: 10.1111/j.1529-8019.2012.01483.x. PMID: 23046017.
Tong LX, Young LC. Nutrition: the future of melanoma prevention? J Am Acad Dermatol. 2014 Jul;71(1):151-60. doi: 10.1016/j.jaad.2014.01.910. Epub 2014 Mar 20. PMID: 24656410.
Johansson H, Spadola G, Tosti G, Mandalà M, Minisini AM, Queirolo P, Aristarco V, Baldini F, Cocorocchio E, Albertazzi E, Zichichi L, Cinieri S, Jemos C, Mazzarol G, Gnagnarella P, Macis D, Tedeschi I, Salè EO, Stucci LS, Bonanni B, Testori A, Pennacchioli E, Ferrucci PF, Gandini S, On Behalf Of The Italian Melanoma Intergroup Imi. Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial. Nutrients. 2021 Jun 4;13(6):1931. doi: 10.3390/nu13061931. PMID: 34199802; PMCID: PMC8226808.
Hyde MA, Grossman D, Wu YP, Buys S, Gren LH, Hashibe M. Vitamin D, melanoma risk, and tumor thickness in PLCO cancer screening trial patients. JAAPA. 2020 Jun;33(6):35-41. doi: 10.1097/01.JAA.0000662388.18867.42. PMID: 32452960.
Kimlin MG, Youl P, Baade P, Rye S, Brodie A. Is Vitamin D Level at Melanoma Diagnosis Associated With Stage Of Tumor? An Observational Study of Melanoma Patients Living in a High Ultraviolet Radiation Environment. Mil Med. 2019 Mar 1;184(Suppl 1):506-510. doi: 10.1093/milmed/usy384. PMID: 30901465.
Fang S, Sui D, Wang Y, Liu H, Chiang YJ, Ross MI, Gershenwald JE, Cormier JN, Royal RE, Lucci A, Wargo J, Hu MI, Gardner JM, Reveille JD, Bassett RL, Wei Q, Amos CI, Lee JE. Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein. J Clin Oncol. 2016 May 20;34(15):1741-7. doi: 10.1200/JCO.2015.64.1357. Epub 2016 Mar 21. PMID: 27001565; PMCID: PMC4966337.
Passarelli MN, Karagas MR, Mott LA, Rees JR, Barry EL, Baron JA. Risk of keratinocyte carcinomas with vitamin D and calcium supplementation: a secondary analysis of a randomized clinical trial. Am J Clin Nutr. 2020 Dec 10;112(6):1532-1539. doi: 10.1093/ajcn/nqaa267. PMID: 33022713; PMCID: PMC7727481
Anand S, Rollakanti KR, Horst RL, Hasan T, Maytin EV. Combination of oral vitamin D3 with photodynamic therapy enhances tumor cell death in a murine model of cutaneous squamous cell carcinoma. Photochem Photobiol. 2014 Sep-Oct;90(5):1126-35. doi: 10.1111/php.12286. Epub 2014 May 26. PMID: 24807677; PMCID: PMC4186664.
Mahamat-Saleh Y, Aune D, Schlesinger S. 25-Hydroxyvitamin D status, vitamin D intake, and skin cancer risk: a systematic review and dose-response meta-analysis of prospective studies. Sci Rep. 2020 Aug 4;10(1):13151. doi: 10.1038/s41598-020-70078-y. PMID: 32753685; PMCID: PMC7403339.
Ince B, Yildirim MEC, Dadaci M. Assessing the Effect of Vitamin D Replacement on Basal Cell Carcinoma Occurrence and Recurrence Rates in Patients with Vitamin D Deficiency. Horm Cancer. 2019 Dec;10(4-6):145-149. doi: 10.1007/s12672-019-00365-2. Epub 2019 Jun 28. PMID: 31254251; PMCID: PMC10355704.
Kuwabara A, Tsugawa N, Tanaka K, Uejima Y, Ogawa J, Otao N, Yamada N, Masaki T, Nishigori C, Moriwaki S, Okano T. High prevalence of vitamin D deficiency in patients with xeroderma pigmetosum-A under strict sun protection. Eur J Clin Nutr. 2015 Jun;69(6):693-6. doi: 10.1038/ejcn.2015.1. Epub 2015 Feb 11. PMID: 25669318.
Global Burden of Disease Cancer Collaboration; Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L, Fleming T, Forouzanfar MH, Hancock J, Hay RJ, Hunter-Merrill R, Huynh C, Hosgood HD, Johnson CO, Jonas JB, Khubchandani J, Kumar GA, Kutz M, Lan Q, Larson HJ, Liang X, Lim SS, Lopez AD, MacIntyre MF, Marczak L, Marquez N, Mokdad AH, Pinho C, Pourmalek F, Salomon JA, Sanabria JR, Sandar L, Sartorius B, Schwartz SM, Shackelford KA, Shibuya K, Stanaway J, Steiner C, Sun J, Takahashi K, Vollset SE, Vos T, Wagner JA, Wang H, Westerman R, Zeeb H, Zoeckler L, Abd-Allah F, Ahmed MB, Alabed S, Alam NK, Aldhahri SF, Alem G, Alemayohu MA, Ali R, Al-Raddadi R, Amare A, Amoako Y, Artaman A, Asayesh H, Atnafu N, Awasthi A, Saleem HB, Barac A, Bedi N, Bensenor I, Berhane A, Bernabé E, Betsu B, Binagwaho A, Boneya D, Campos-Nonato I, Castañeda-Orjuela C, Catalá-López F, Chiang P, Chibueze C, Chitheer A, Choi JY, Cowie B, Damtew S, das Neves J, Dey S, Dharmaratne S, Dhillon P, Ding E, Driscoll T, Ekwueme D, Endries AY, Farvid M, Farzadfar F, Fernandes J, Fischer F, G/Hiwot TT, Gebru A, Gopalani S, Hailu A, Horino M, Horita N, Husseini A, Huybrechts I, Inoue M, Islami F, Jakovljevic M, James S, Javanbakht M, Jee SH, Kasaeian A, Kedir MS, Khader YS, Khang YH, Kim D, Leigh J, Linn S, Lunevicius R, El Razek HMA, Malekzadeh R, Malta DC, Marcenes W, Markos D, Melaku YA, Meles KG, Mendoza W, Mengiste DT, Meretoja TJ, Miller TR, Mohammad KA, Mohammadi A, Mohammed S, Moradi-Lakeh M, Nagel G, Nand D, Le Nguyen Q, Nolte S, Ogbo FA, Oladimeji KE, Oren E, Pa M, Park EK, Pereira DM, Plass D, Qorbani M, Radfar A, Rafay A, Rahman M, Rana SM, Søreide K, Satpathy M, Sawhney M, Sepanlou SG, Shaikh MA, She J, Shiue I, Shore HR, Shrime MG, So S, Soneji S, Stathopoulou V, Stroumpoulis K, Sufiyan MB, Sykes BL, Tabarés-Seisdedos R, Tadese F, Tedla BA, Tessema GA, Thakur JS, Tran BX, Ukwaja KN, Uzochukwu BSC, Vlassov VV, Weiderpass E, Wubshet Terefe M, Yebyo HG, Yimam HH, Yonemoto N, Younis MZ, Yu C, Zaidi Z, Zaki MES, Zenebe ZM, Murray CJL, Naghavi M. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2017 Apr 1;3(4):524-548. doi: 10.1001/jamaoncol.2016.5688. Erratum in: JAMA Oncol. 2017 Mar 1;3(3):418. PMID: 27918777; PMCID: PMC6103527.
Krishnan AV, Peehl DM, Feldman D. The role of vitamin D in prostate cancer. Recent Results Cancer Res. 2003;164:205-21. doi: 10.1007/978-3-642-55580-0_15. PMID: 12899524.
Zhang ZH, Liu MD, Yao K, Xu S, Yu DX, Xie DD, Xu DX. Vitamin D deficiency aggravates growth and metastasis of prostate cancer through promoting EMT in two β-catenin-related mechanisms. J Nutr Biochem. 2023 Jan;111:109177. doi: 10.1016/j.jnutbio.2022.109177. Epub 2022 Oct 9. PMID: 36223833.
Fang F, Kasperzyk JL, Shui I, Hendrickson W, Hollis BW, Fall K, Ma J, Gaziano JM, Stampfer MJ, Mucci LA, Giovannucci E. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One. 2011 Apr 6;6(4):e18625. doi: 10.1371/journal.pone.0018625. PMID: 21494639; PMCID: PMC3071841.
Jiang X, Dimou NL, Al-Dabhani K, Lewis SJ, Martin RM, Haycock PC, Gunter MJ, Key TJ, Eeles RA, Muir K, Neal D, Giles GG, Giovannucci EL, Stampfer M, Pierce BL, Schildkraut JM, Warren Andersen S, Thompson D, Zheng W, Kraft P, Tsilidis KK; PRACTICAL, CRUK, BPC3, CAPS and PEGASUS consortia. Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study. Int J Epidemiol. 2019 Oct 1;48(5):1416-1424. doi: 10.1093/ije/dyy284. PMID: 30597039; PMCID: PMC6934026.
Dimitrakopoulou VI, Tsilidis KK, Haycock PC, Dimou NL, Al-Dabhani K, Martin RM, Lewis SJ, Gunter MJ, Mondul A, Shui IM, Theodoratou E, Nimptsch K, Lindström S, Albanes D, Kühn T, Key TJ, Travis RC, Vimaleswaran KS; GECCO Consortium; PRACTICAL Consortium; GAME-ON Network (CORECT, DRIVE, ELLIPSE, FOCI-OCAC, TRICL-ILCCO); Kraft P, Pierce BL, Schildkraut JM. Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study. BMJ. 2017 Oct 31;359:j4761. doi: 10.1136/bmj.j4761. PMID: 29089348; PMCID: PMC5666592.
Grimm M, Shokri B, Alexander D, Munz A, Hoffmann J, Reinert S. Is 1,25-dihydroxyvitamin D3 receptor expression a potential Achilles' heel of CD44+ oral squamous cell carcinoma cells? Target Oncol. 2013 Sep;8(3):189-201. doi: 10.1007/s11523-013-0255-z. Epub 2013 Jan 15. Erratum in: Target Oncol. 2017 Jul 26;: PMID: 23314953.
Fathi N, Ahmadian E, Shahi S, Roshangar L, Khan H, Kouhsoltani M, Maleki Dizaj S, Sharifi S. Role of vitamin D and vitamin D receptor (VDR) in oral cancer. Biomed Pharmacother. 2019 Jan;109:391-401. doi: 10.1016/j.biopha.2018.10.102. Epub 2018 Nov 3. PMID: 30399574.
Lipworth L, Rossi M, McLaughlin JK, Negri E, Talamini R, Levi F, Franceschi S, La Vecchia C. Dietary vitamin D and cancers of the oral cavity and esophagus. Ann Oncol. 2009 Sep;20(9):1576-1581. doi: 10.1093/annonc/mdp036. Epub 2009 Jun 1. PMID: 19487490.
Anand A, Singh S, Sonkar AA, Husain N, Singh KR, Singh S, Kushwaha JK. Expression of vitamin D receptor and vitamin D status in patients with oral neoplasms and effect of vitamin D supplementation on quality of life in advanced cancer treatment. Contemp Oncol (Pozn). 2017;21(2):145-151. doi: 10.5114/wo.2017.68623. Epub 2017 Jun 30. PMID: 28947884; PMCID: PMC5611504.
Botelho J, Machado V, Proença L, Delgado AS, Mendes JJ. Vitamin D Deficiency and Oral Health: A Comprehensive Review. Nutrients. 2020; 12(5):1471. https://doi.org/10.3390/nu12051471
Budny A, Starosławska E, Budny B, Wójcik R, Hys M, Kozłowski P, Budny W, Brodzik A, Burdan F. Epidemiology and diagnosis of breast cancer. Pol Merkur Lekarski. 2019 May 27;46(275):195-204. Polish. PMID: 31152530.
Thabet RH, Gomaa AA, Matalqah LM, Shalaby EM. Vitamin D: an essential adjuvant therapeutic agent in breast cancer. J Int Med Res. 2022 Jul;50(7):3000605221113800. doi: 10.1177/03000605221113800. PMID: 35883275; PMCID: PMC9340350.
Janowsky, E., Lester, G., Weinberg, C., Millikan, R., Schildkraut, J., Garrett, P., & Hulka, B. (1999). Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Public Health Nutrition, 2(3), 283-291. doi:10.1017/S1368980099000385
Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study. Carcinogenesis. 2008 Jan;29(1):93-9. doi: 10.1093/carcin/bgm240. Epub 2007 Oct 31. PMID: 17974532.
Shamsi U, Khan S, Azam I, Habib Khan A, Maqbool A, Hanif M, et al. (2020) A multicenter case control study of association of vitamin D with breast cancer among women in Karachi, Pakistan. PLoS ONE 15(1): e0225402. https://doi.org/ 10.1371/journal.pone.0225402
Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017 Apr;66(4):683-691. doi: 10.1136/gutjnl-2015-310912. Epub 2016 Jan 27. PMID: 26818619.
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP; CONCORD Working Group. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015 Mar 14;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9. Epub 2014 Nov 26. Erratum in: Lancet. 2015 Mar 14;385(9972):946. PMID: 25467588; PMCID: PMC4588097.
González-Sancho JM, Larriba MJ, Ordóñez-Morán P, Pálmer HG, Muñoz A. Effects of 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Anticancer Res. 2006 Jul-Aug;26(4A):2669-81. PMID: 16886677.
Pereira F, Larriba MJ, Muñoz A. Vitamin D and colon cancer. Endocr Relat Cancer. 2012 May 3;19(3):R51-71. doi: 10.1530/ERC-11-0388. PMID: 22383428
Li J, Qin S, Zhang S, Lu Y, Shen Q, Cheng L, Zhong R. Serum vitamin D concentration, vitamin D-related polymorphisms, and colorectal cancer risk. Int J Cancer. 2023 Jul 15;153(2):278-289. doi: 10.1002/ijc.34521. Epub 2023 Mar 29. PMID: 36946647.
Izumi D, Ishimoto T, Miyake K, Eto T, Arima K, Kiyozumi Y, Uchihara T, Kurashige J, Iwatsuki M, Baba Y, Sakamoto Y, Miyamoto Y, Yoshida N, Watanabe M, Goel A, Tan P, Baba H. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc. Stem Cells. 2017 Sep;35(9):2027-2036. doi: 10.1002/stem.2668. Epub 2017 Jul 31. PMID: 28699179.
Xu J, Li L, Shi P, Cui H, Yang L. The Crucial Roles of Bmi-1 in Cancer: Implications in Pathogenesis, Metastasis, Drug Resistance, and Targeted Therapies. Int J Mol Sci. 2022 Jul 26;23(15):8231. doi: 10.3390/ijms23158231. PMID: 35897796; PMCID: PMC9367737.
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012 May 25;149(5):1060-72. doi: 10.1016/j.cell.2012.03.042. PMID: 22632970; PMCID: PMC3367386.
Taylor WR, Fedorka SR, Gad I, Shah R, Alqahtani HD, Koranne R, Kuganesan N, Dlamini S, Rogers T, Al-Hamashi A, Kholodovych V, Barudi Y, Junk D, Rashid MS, Jackson MW, Tillekeratne LMV. Small-Molecule Ferroptotic Agents with Potential to Selectively Target Cancer Stem Cells. Sci Rep. 2019 Apr 11;9(1):5926. doi: 10.1038/s41598-019-42251-5. PMID: 30976078; PMCID: PMC6459861.
Bacchetta J, Zaritsky JJ, Sea JL, Chun RF, Lisse TS, Zavala K, Nayak A, Wesseling-Perry K, Westerman M, Hollis BW, Salusky IB, Hewison M. Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrol. 2014 Mar;25(3):564-72. doi: 10.1681/ASN.2013040355. Epub 2013 Nov 7. PMID: 24204002; PMCID: PMC3935584.
Guo S, Zhao W, Zhang W, Li S, Teng G, Liu L. Vitamin D Promotes Ferroptosis in Colorectal Cancer Stem Cells via SLC7A11 Downregulation. Oxid Med Cell Longev. 2023 Feb 16;2023:4772134. doi: 10.1155/2023/4772134. PMID: 36846715; PMCID: PMC9950793.
Płudowski P, Kos-Kudła B, Walczak M, Fal A, Zozulińska-Ziółkiewicz D, Sieroszewski P, Peregud-Pogorzelski J, Lauterbach R, Targowski T, Lewiński A, Spaczyński R, Wielgoś M, Pinkas J, Jackowska T, Helwich E, Mazur A, Ruchała M, Zygmunt A, Szalecki M, Bossowski A, Czech-Kowalska J, Wójcik M, Pyrżak B, Żmijewski MA, Abramowicz P, Konstantynowicz J, Marcinowska-Suchowierska E, Bleizgys A, Karras SN, Grant WB, Carlberg C, Pilz S, Holick MF, Misiorowski W.Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients. 2023 Jan 30;15(3):695. doi: 10.3390/nu15030695. PMID: 36771403; PMCID: PMC9920487.ttps://pubmed.ncbi.nlm.nih.gov/36771403/
Botelho J, Machado V, Proença L, Delgado AS, Mendes JJ. Vitamin D Deficiency and Oral Health: A Comprehensive Review. Nutrients. 2020 May 19;12(5):1471. doi: 10.3390/nu12051471. PMID: 32438644; PMCID: PMC7285165. https://pubmed.ncbi.nlm.nih.gov/32438644/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Gabriela Różańska-Smuszkiewicz, Karolina Koszyczarek, Maja Kotowska, Wiktoria Zamirska, Albin Ziemiański, Katarzyna Zięba, Anna Zygmunt, Paweł Smuszkiewicz-Różański
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 295
Number of citations: 0
